Literature DB >> 35623004

Building the Canadian Bladder Cancer Research Network (CBCRN): Progress during a pandemic.

Peter C Black1, Nimira Alimohamed2, Wassim Kassouf3, John L Gore4, Kathy D McCoy5, Brad H Nelson6, Daniel D De Carvalho7,8, Rodney J Ouellette9, Ferg Devins10, Tony Cornacchia10, D Robert Siemens11, David M Berman12, Srikala S Sridhar13, Girish Kulkarni14.   

Abstract

Entities:  

Year:  2022        PMID: 35623004      PMCID: PMC9245967          DOI: 10.5489/cuaj.7810

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   2.052


× No keyword cloud information.
  46 in total

1.  Testing criterion-based benchmarking for the appropriate use of radiotherapy.

Authors:  Michael B Barton; Gabriel S Gabriel; Geoffrey P Delaney
Journal:  Radiother Oncol       Date:  2018-06-04       Impact factor: 6.280

2.  The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers.

Authors:  Julian Smazynski; Phineas T Hamilton; Shelby Thornton; Katy Milne; Maartje C A Wouters; John R Webb; Brad H Nelson
Journal:  Gynecol Oncol       Date:  2020-05-20       Impact factor: 5.482

Review 3.  The microbiome, cancer, and cancer therapy.

Authors:  Beth A Helmink; M A Wadud Khan; Amanda Hermann; Vancheswaran Gopalakrishnan; Jennifer A Wargo
Journal:  Nat Med       Date:  2019-03-06       Impact factor: 53.440

4.  DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats.

Authors:  David Brocks; Christopher R Schmidt; Michael Daskalakis; Hyo Sik Jang; Nakul M Shah; Daofeng Li; Jing Li; Bo Zhang; Yiran Hou; Sara Laudato; Daniel B Lipka; Johanna Schott; Holger Bierhoff; Yassen Assenov; Monika Helf; Alzbeta Ressnerova; Md Saiful Islam; Anders M Lindroth; Simon Haas; Marieke Essers; Charles D Imbusch; Benedikt Brors; Ina Oehme; Olaf Witt; Michael Lübbert; Jan-Philipp Mallm; Karsten Rippe; Rainer Will; Dieter Weichenhan; Georg Stoecklin; Clarissa Gerhäuser; Christopher C Oakes; Ting Wang; Christoph Plass
Journal:  Nat Genet       Date:  2017-06-12       Impact factor: 38.330

5.  The kidney cancer research priority-setting partnership: Identifying the top 10 research priorities as defined by patients, caregivers, and expert clinicians.

Authors:  Jennifer Jones; Jaimin Bhatt; Jonathan Avery; Andreas Laupacis; Katherine Cowan; Naveen Basappa; Joan Basiuk; Christina Canil; Sohaib Al-Asaaed; Daniel Heng; Lori Wood; Dawn Stacey; Christian Kollmannsberger; Michael A S Jewett
Journal:  Can Urol Assoc J       Date:  2017-11-01       Impact factor: 1.862

6.  Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers.

Authors:  Wouter Scheper; Sander Kelderman; Lorenzo F Fanchi; Carsten Linnemann; Gavin Bendle; Marije A J de Rooij; Christian Hirt; Riccardo Mezzadra; Maarten Slagter; Krijn Dijkstra; Roelof J C Kluin; Petur Snaebjornsson; Katy Milne; Brad H Nelson; Henry Zijlmans; Gemma Kenter; Emile E Voest; John B A G Haanen; Ton N Schumacher
Journal:  Nat Med       Date:  2018-12-03       Impact factor: 53.440

7.  Affinity Captured Urinary Extracellular Vesicles Provide mRNA and miRNA Biomarkers for Improved Accuracy of Prostate Cancer Detection: A Pilot Study.

Authors:  Michelle Davey; Sami Benzina; Marc Savoie; Guy Breault; Anirban Ghosh; Rodney J Ouellette
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

8.  Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency.

Authors:  Parinaz Mehdipour; Sajid A Marhon; Ilias Ettayebi; Ankur Chakravarthy; Amir Hosseini; Yadong Wang; Fabíola Attié de Castro; Helen Loo Yau; Charles Ishak; Sagi Abelson; Catherine A O'Brien; Daniel D De Carvalho
Journal:  Nature       Date:  2020-10-21       Impact factor: 49.962

9.  Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses.

Authors:  Israel Cañadas; Rohit Thummalapalli; Jong Wook Kim; Shunsuke Kitajima; Russell William Jenkins; Camilla Laulund Christensen; Marco Campisi; Yanan Kuang; Yanxi Zhang; Evisa Gjini; Gao Zhang; Tian Tian; Debattama Rai Sen; Diana Miao; Yu Imamura; Tran Thai; Brandon Piel; Hideki Terai; Amir Reza Aref; Timothy Hagan; Shohei Koyama; Masayuki Watanabe; Hideo Baba; Anika Elise Adeni; Christine Anne Lydon; Pablo Tamayo; Zhi Wei; Meenhard Herlyn; Thanh Uyen Barbie; Ravindra Uppaluri; Lynnette Marie Sholl; Ewa Sicinska; Jacob Sands; Scott Rodig; Kwok Kin Wong; Cloud Peter Paweletz; Hideo Watanabe; David Allen Barbie
Journal:  Nat Med       Date:  2018-07-23       Impact factor: 53.440

10.  B cells and tertiary lymphoid structures promote immunotherapy response.

Authors:  Beth A Helmink; Sangeetha M Reddy; Jianjun Gao; Shaojun Zhang; Rafet Basar; Rohit Thakur; Keren Yizhak; Moshe Sade-Feldman; Jorge Blando; Guangchun Han; Vancheswaran Gopalakrishnan; Yuanxin Xi; Hao Zhao; Rodabe N Amaria; Hussein A Tawbi; Alex P Cogdill; Wenbin Liu; Valerie S LeBleu; Fernanda G Kugeratski; Sapna Patel; Michael A Davies; Patrick Hwu; Jeffrey E Lee; Jeffrey E Gershenwald; Anthony Lucci; Reetakshi Arora; Scott Woodman; Emily Z Keung; Pierre-Olivier Gaudreau; Alexandre Reuben; Christine N Spencer; Elizabeth M Burton; Lauren E Haydu; Alexander J Lazar; Roberta Zapassodi; Courtney W Hudgens; Deborah A Ledesma; SuFey Ong; Michael Bailey; Sarah Warren; Disha Rao; Oscar Krijgsman; Elisa A Rozeman; Daniel Peeper; Christian U Blank; Ton N Schumacher; Lisa H Butterfield; Monika A Zelazowska; Kevin M McBride; Raghu Kalluri; James Allison; Florent Petitprez; Wolf Herman Fridman; Catherine Sautès-Fridman; Nir Hacohen; Katayoun Rezvani; Padmanee Sharma; Michael T Tetzlaff; Linghua Wang; Jennifer A Wargo
Journal:  Nature       Date:  2020-01-15       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.